Linked Life Data

17449138

Source:http://linkedlifedata.com/resource/pubmed/id/17449138

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-7-16
pubmed:abstractText
Though the imaging-based response (IBR) is the most frequently used index of the therapeutic effect in cancer patients, an index based on serum tumor markers might prove to be useful, especially in patients without measurable tumors.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0169-5002
pubmed:author
pubmed:issnType
Print
pubmed:volume
57
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
213-21
pubmed:meshHeading
pubmed-meshheading:17449138-Adult, pubmed-meshheading:17449138-Aged, pubmed-meshheading:17449138-Aged, 80 and over, pubmed-meshheading:17449138-Antineoplastic Agents, pubmed-meshheading:17449138-CA-125 Antigen, pubmed-meshheading:17449138-CA-19-9 Antigen, pubmed-meshheading:17449138-Carcinoembryonic Antigen, pubmed-meshheading:17449138-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:17449138-Cohort Studies, pubmed-meshheading:17449138-Female, pubmed-meshheading:17449138-Humans, pubmed-meshheading:17449138-Lung Neoplasms, pubmed-meshheading:17449138-Male, pubmed-meshheading:17449138-Middle Aged, pubmed-meshheading:17449138-Predictive Value of Tests, pubmed-meshheading:17449138-Quinazolines, pubmed-meshheading:17449138-Survival Analysis, pubmed-meshheading:17449138-Treatment Outcome, pubmed-meshheading:17449138-Tumor Markers, Biological
pubmed:year
2007
pubmed:articleTitle
Serum tumor markers as predictors for survival in advanced non-small cell lung cancer patients treated with gefitinib.
pubmed:affiliation
Section of Thoracic Oncology, Chest Department, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't